You are here

Editorial

R&D Redux

David B. Nash, MD, MBA
PDF version: 
Although skeptics say fixing Big Pharma is not possible, David B. Nash, MD, MBA, describes a “cultural revolution” in which small elite groups within centers of excellence could revitalize R&D.